Got cash to spare? Starting soon, Gates Foundation will accept it

This year the Bill & Melinda Gates Foundation accepted its largest pledge ever — more than $30 billion from a high-powered investor named Warren. Next year it will accept its smallest — $35 from a 7-year-old girl named Olivia.

Read here.

December 2, 2006 in economy | Permalink | Comments (0)

Biogen, Elan Voluntarily Withdraw MS Drug

More info here.

February 28, 2005 in antegren , avonex, bummer, economy, follow the money..., tysabri | Permalink | Comments (0)

Irish drugmaker Elan narrows quarter loss

Irish pharmaceutical company Elan Corp.'s first-quarter loss narrowed amid reduced operating expenses.

The company also said it is on track to seek approval for its highly anticipated multiple sclerosis drug, Antegren....

Elan is developing Antegren with Biogen Idec Inc., of Cambridge, Mass. In February, the two companies said they planned to file for approval of Antegren a year ahead of schedule. Biogen Idec already sells the MS drug Avonex.

More here.

May 16, 2004 in antegren , economy, follow the money..., stocks, tysabri | Permalink | Comments (0)

Biogen Idec, Elan to submit MS drug for European approval

Biogen Idec and Elan Corp. plc said Tuesday that they plan to submit their multiple sclerosis drug Antegren for approval in Europe.

The filing will be made to the European Agency for the Evaluation of Medicinal Products in the summer of 2004.

More here.

March 23, 2004 in antegren , economy, follow the money..., stocks, tysabri | Permalink | Comments (0)

Converging on MS

A group of local doctors is forming an innovative treatment-and-research hub for multiple sclerosis, a mysterious, debilitating disease that, on a per capita basis, afflicts more people in Washington than in any other state.

The newly formed not-for-profit MS Hub plans to serve MS patients in a five-state region that includes Washington, Idaho, Montana, Alaska and Hawaii.
If it opens as planned in July, in a 40,000-square-foot clinic in Seattle's Metropolitan Park office complex near South Lake Union, it will be the largest such MS center in the world, said founding neurologist Craig Smith.

More here.

Craig runs a small clinic in Anchorage, no wonder it's been hard to get an appointment with him.

More info on MS and the Pacific Northwest:
Northwest research centers among leaders in unraveling mystery of MS
VA funds Northwest center to battle MS

"This is a great opportunity to improve care for 50,000 veterans in the U.S. who have multiple sclerosis," said Dr. Dennis Bourdette, co-director for the new MS Center of Excellence West. Bourdette also is a staff neurologist at the Portland VAMC, interim chair of the Department of Neurology at Oregon Health & Science University and co-director of the MS Center of Oregon.

March 4, 2004 in alaska, diagnosis, economy, follow the money..., treatment | Permalink | Comments (0)

Biogen Idec and Elan to Seek Earlier MS Drug Approval

Biogen Idec Inc. and Elan Corp. said they will apply for U.S. approval of their experimental Antegren multiple sclerosis drug by July, speeding potential clearance of the product by as much as year. Shares of both companies soared.

More here.

February 19, 2004 in antegren , economy, follow the money..., research | Permalink | Comments (0)

Elan Says Antegren Trial for Crohn's Successful

Irish pharmaceutical firm Elan Corp Plc raised market hopes for its much-vaunted experimental drug Antegren on Thursday after it announced successful results from a key clinical trial on Crohn's disease.

Data from Phase III studies of Antegren's effect on MS are expected by late 2004 or early 2005.

More here.

February 1, 2004 in antegren , economy, follow the money..., research | Permalink | Comments (1)

FDA Big Factor Behind High Drug Costs

The U.S. Food and Drug Administration, with its costly and time-consuming drug approval process, is a big reason Americans pay far more for medicine than consumers in the rest of the world, U.S. Nobel laureate Milton Friedman said on Tuesday.

More here.

January 30, 2004 in economy, follow the money..., politics | Permalink | Comments (0)

Ecuador Maps 20-Year Plan to Slow Deforestation

oldgrowth.jpgThe jungle was beautiful, but the picture on the right is the only old growth tree (yes it is a tree and not a cliff) we saw on a week long boat trip in Ecuador.

Ecuador, which lost more of its forest cover than any other nation in South America in the 1990s, is developing a 20-year plan to work with the private sector to plant new trees and protect old forest.

Chop here.

December 10, 2003 in economy, ecuador, environment, Travel | Permalink | Comments (0)

Central nervous system big money

Central nervous system (CNS) treatments are big business – and are growing at the fastest rate among the largest therapeutic categories. The global sales of CNS therapeutics are second only to those sold for cardiovascular ailments.

One of the fastest growing markets is in treatments for multiple sclerosis, which grew by 21 percent in 2002. Due to a frustrating history of ineffective MS treatments, doctors and patients are embracing these biotech innovations.

Read here.

December 8, 2003 in avonex, economy, follow the money..., rebif, stocks | Permalink | Comments (0)